LATS2 and chronic myelogenous leukemia, BCR-ABL1 positive: To determine whether our Thai CML patients who are resistant to IM treatment also had high expression of LATS, we determined the expression of LATS1 and LATS2 transcripts in 60 adult CML patients diagnosed with the presence of the Philadelphia chromosome and the BCR–ABL fusion gene compared to healthy donors.